NEW YORK (GenomeWeb) – Next-generation sequencing-based clinical diagnostics firm Blueprint Genetics today announced it has raised $3.9 million to fund its international expansion.

It is unclear if the $3.9 million figure is the amount the Finnish firm raised in the most recent financing round or if it is the total amount raised since its founding. On deadlinie, the company did not respond to a request for clarification.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.